Caron Jacobson, MD - Where Do Antibody–Drug Conjugates Fit in Relapsed/Refractory Diffuse Large B-Cell Lymphoma? Addressing Community Questions and Real-World Approaches to Selecting and Sequencing Novel Therapies

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NHL Metropolitan Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 11PM EDT 5 min · 25 Sep 2026 · NPR News Now

We're Going Back To Mortis? 'Ahsoka' Season 2 Details Revealed! | The SWU Podcast LIVE 1h 39m · 25 Sep 2026 · The Star Wars Underworld Podcast

Microsoft AI Boss: “A Silicon Species” Could Compete With HumansMicrosoft AI Boss: “A Silicon Species” Could Compete With Humans 38 min · 25 Sep 2026 · AI Haven't A Clue

Who are the "passport bros" travelling abroad to find love? 5 min · 25 Sep 2026 · Do you really know?

Can plate colour really affect our sense of taste? 5 min · 25 Sep 2026 · Do you really know?

Report any issue

Source

Recorded25 Nov 2025

Publisherc.answersincme.com ↗

Handlerec:11443603

Show notes

Please visit answersincme.com/CAZ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology-oncology answers the most commonly asked questions from clinicians about the management of relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) with antibody–drug conjugates (ADCs). Upon completion of this activity, participants should be better able to: Identify patients with R/R DLBCL who may benefit from ADC therapy in the third-line or later setting; Interpret current evidence to inform selection of ADC therapies for patients with R/R DLBCL in the third-line or later setting; and Discuss strategies to optimize the use of ADC therapies for patients with R/R DLBCL, particularly in the community setting.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in